Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

Peter M Calverley1 Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UKCorrespondence[email protected]

Dirkje S Postma2 Department of Pulmonary Medicine and Tuberculosis, Gronigen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

Antonio R Anzueto3 Division of Pulmonary Diseases and Critical Care Medicine, University of Texas Health Sciences Center, School of Medicine, University of Texas, San Antonio, TX, USA;4 South Texas Veterans Health Care System, San Antonio, TX, USA

Barry J Make5 Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO, USA

Göran Eriksson6 Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden

Stefan Peterson7 StatMind AB, Lund, Sweden

Christine R Jenkins8 George Institute for Global Health, Concord Clincal School, The University of Sydney, Sydney, NSW, Australia

show all

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date